Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Rhein promotes TRAIL-induced apoptosis in bladder cancer cells by up-regulating DR5 expression.
RH promoted bladder cancer cell apoptosis by up-regulating DR5 expression.
»
03/22/22
Health-related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R-04.
Obese/overweight patients had statistically significantly worse FACT-C Trial Outcome Index scores.
»
05/10/22
Inhibition of the PIN1-NRF2/GPX4 axis imparts sensitivity to cisplatin in cervical cancer cells.
Cisplatin (DDP) induces ferroptosis.
»
08/19/22
Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study
All-cause mortality lower in university versus non-university hospitals.
»
08/19/22
Real-world patient characteristics and treatment outcomes among nontransplanted multiple myeloma patients who received Bortezomib in combination with Lenalidomide and Dexamethasone as first line of therapy in the United States
Median PFS observed in real-world practice notably shorter than observed in SWOG S0777 clinical trial.
»
08/18/22
Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy
Time developing motor deficits >14 days and pre-treatment ambulatory status significantly associated with successful treatment.
»
08/17/22
Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors
Increased susceptibility of HCC PDXOs towards proteasome inhibitors.
»
08/15/22
Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study
Surgery for primary or metastatic site did not affect survival.
»
08/15/22
Impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany.
Two-year overall survival from 1L initiation 36.8 % and 25.6 % in squamous cohorts.
»
04/19/22
Risk and tropism of central nervous system (CNS) metastases in patients with stage II and III cutaneous melanoma.
Patients with stage III melanoma had higher rate of developing brain metastases than those with stage II melanoma.
»
06/21/22
< Prev
Next >